Aratana Therapeutics reports plans to price public offering of shares

Bookrunners Jefferies and Barclays to assist with sale of common stock

By Devika Patel

Knoxville, Tenn., Sept. 16 – Aratana Therapeutics, Inc. will price a public offering of common stock with a 30-day greenshoe option, according to a preliminary prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Jefferies and Barclays are the joint bookrunning managers.

Proceeds will be used for development of therapeutic candidates, expansion of commercial infrastructure and for other general corporate and working capital purposes.

Based in Kansas City, Kan., the development-stage biopharmaceutical company is focused on pet medications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.